Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
<h4>Background</h4>Every year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with improved prognosis. This stud...
Guardado en:
Autores principales: | Paul H van der Horst, Yongyi Wang, Ingrid Vandenput, Liesbeth C Kühne, Patricia C Ewing, Wilfred F J van Ijcken, Marten van der Zee, Frederic Amant, Curt W Burger, Leen J Blok |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2b97bfee31c43be916121a5f545b551 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Progesterone, Myo-Inositol, Dopamine and Prolactin Present in Follicular Fluid Have Differential Effects on Sperm Motility Subpopulations
por: Shannen Keyser, et al.
Publicado: (2021) -
Morphological Characteristics and Expression of Estrogen and Progesterone Receptors in the Canine Endometrium During the Estrus Cycle, Cystic Endometrial Hyperplasia and Pyometra
por: Marinković Darko, et al.
Publicado: (2018) -
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Jenneke C. Kasius, et al.
Publicado: (2021) -
Progesterone prevents epithelial-mesenchymal transition of ovine amniotic epithelial cells and enhances their immunomodulatory properties
por: Angelo Canciello, et al.
Publicado: (2017) -
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer
por: Franceska Dedeurwaerdere, et al.
Publicado: (2021)